Efficacy and Safety of Rivaroxaban Compared with Other Therapies ...

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary ...

The primary efficacy outcome occurred in 50 patients (2.1%) in the rivaroxaban group as compared with 44 patients (1.8%) in the standard-therapy ...

Efficacy and Safety of Rivaroxaban Therapy for Patients With ...

Compared with control, rivaroxaban therapy did not reduce the risks of myocardial infarction (0.87, 0.73 to 1.04, p = 0.12), ischemic stroke (0.85, CI 0.68 to ...

Efficacy and Safety of Rivaroxaban Compared with Other Therapies ...

There was no evidence for differences between RIV plus ASA and dual antiplatelet therapy and vitamin K antagonists plus ASA. Similar results ...

Systematic review and meta-analysis of the efficacy and safety of ...

Hence, apixaban and rivaroxaban are now increasingly used for acute VTE compared with VKAs and other DOACs.3. Although DOAC use in VTE has been ...

Efficacy and safety of rivaroxaban compared with warfarin in patients ...

The safety of rivaroxaban vs warfarin for major or nonmajor clinically relevant bleeding was similar in patients with and without CD (interaction P = 0.64).

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin ...

We hypothesized that rivaroxaban would be an effective and safe treatment option for NVAF patients with obesity and polypharmacy compared to ...

Comparative effectiveness of rivaroxaban in the treatment of ...

When the odds of major or clinically relevant bleeding in each study were compared with each other, the risk was 34% lower in apixaban compared with rivaroxaban ...

COMPARATIVE EFFICACY AND SAFETY OF RIVAROXABAN ...

Dual-pathway therapy with rivaroxaban plus aspirin or a P2Y12 inhibitor may be an effective and safe alternative to DAPT in the post-ACS setting. Download ...

Efficacy and Safety of Rivaroxaban in Patients with Heart Failure ...

The findings comparing rivaroxaban with warfarin among patient with HF were similar to the overall trial findings. Thus, the authors concluded ...

Comparison of the efficacy and safety of new oral anticoagulants ...

Low-dose new oral anticoagulant regimens showed similar overall reductions in stroke or systemic embolic events to warfarin (1·03, 0·84–1·27; p= ...

Efficacy and Safety of Rivaroxaban in Prevention and Therapy of ...

Rivaroxaban is an oral direct factor Xa inhibitor reducing the risk of systemic embolism and stroke in patients with nonvalvular atrial fibrillation. Aims: The ...

Effectiveness and safety of rivaroxaban in patients with venous ...

There was no difference in the initial dose distribution of rivaroxaban between patients with and without active cancer. The incidences of recurrence or ...

Efficacy and Safety of Rivaroxaban Versus Enoxaparin in Prevention ...

Rivaroxaban can serve as a viable alternative to enoxaparin, with no appreciable drawbacks, for preventing and managing VTE in patients with ...

Efficacy and safety of rivaroxaban in patients with diabetes and ...

The relative efficacy of rivaroxaban and warfarin for prevention of stroke and systemic embolism was similar in patients with (1.74 vs 2.14/100 patient-years, ...

Effectiveness and Safety of Different Rivaroxaban Dosage ... - Nature

Appropriate anticoagulation therapy can effectively lower the risk of thromboembolism. For decades, vitamin K antagonists were the only option ...

Effectiveness and safety of rivaroxaban compared with low ...

It was associated with a reduction in recurrent VTE risk (HR, 0.37; 95% CI, 0.15-0.95), but no significant difference in major bleeding (HR, ...

Safety and Efficacy of Rivaroxaban for Extended-Phase ... - MDPI

Discussion: Rivaroxaban appears to be safe and effective for the long-term treatment of patients with recurrent or unprovoked VTE. Our results ...

Safety and effectiveness of oral rivaroxaban versus standard ...

The efficacy and safety of the anticoagulant rivaroxaban for the treatment and secondary prevention of deep-vein thrombosis and pulmonary ...

Effectiveness and safety of rivaroxaban for anticoagulation therapy ...

Thrombotic events were significantly reduced in the rivaroxaban prophylaxis group compared to the placebo control group. However, the reduction ...

Head-to-head efficacy and safety of rivaroxaban, apixaban, and ...

Patients treated with rivaroxaban demonstrated lower rate of intracranial haemorrhage compared with apixaban (HR,0.86; 95% CI,0.74-1.0; P,0.044). The rate of ...